Technology 🌍 BR 🔗 Tecnoblog 🌐 Translated

🗓️ 06/06/2026 06:29

The United Kingdom begins to test vaccines made with the help of AI (image: Pexels/Gustavo Fring) Summary PEVAC-PS vaccine, developed with the aid of artificial intelligence, has completed its first phase of evaluation in humans in the United Kingdom. Tests recorded no significant side effects and showed that the concept works. The research, carried out by the University of Cambridge, evaluated the vaccine in 39 healthy volunteers and is already preparing a new round of tests. An experimental vaccine developed with the aid of artificial intelligence can act against future coronavirus mutations. In trials in the UK, PEVAC-PS completed its first phase of evaluation in humans and recorded no significant side effects. The vaccine was developed by researchers at the University of Cambridge in England and evaluated in 39 healthy volunteers. The proposal is that it can act against different types of sarbecoviruses, a group that includes SARS-CoV-1, SARS-CoV-2 variants (which caused the Covid-

This is a summary. To read the full article:

📰 Read full article ↗

Share: WhatsApp LINE Twitter/X